59/100B29.390
USD
-0.49
(-1.64%)
Post Trading·29.320USD-0.070(-0.24%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.72Revenue estimate 17.14B
Q4 FY2026 · Earnings report
EPS estimate 0.72Revenue estimate 17.14B
Pfizer return on equity (ROE)
Pfizer's return on equity is 4.57%: net income of 4.07B USD over the last twelve months on shareholders' equity of 89.00B USD.
- Today
- 4.57%
- Average, 5 years
- 14.94%
- Low, 5 years
- -2.92%
- High, 5 years
- 34.13%
ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 4.07B ÷ 89.00B = 4.57%
ROE (return on equity)
Net income
Shareholders' equity
Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.
Why is Pfizer's return on equity so high?
Net margin
12.4%
profit on each dollar of sales
×
Asset turnover
0.30×
sales on each dollar of assets
×
Equity multiplier
2.41×
assets on each dollar of equity
=
Return on equity
9.0%
FY2025
- FY202512.4% × 0.30 × 2.41 = 9.0%
- FY202412.6% × 0.30 × 2.42 = 9.1%
- FY20233.6% × 0.26 × 2.54 = 2.4%
- FY202231.0% × 0.51 × 2.06 = 32.8%
- FY202127.0% × 0.45 × 2.35 = 28.5%
The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.
ROE (return on equity) by year and by quarter
| Fiscal year | Period ending | ROE (return on equity) | Net income | Shareholders' equity |
|---|---|---|---|---|
| Today | 4.57% | 4.07B | 89.00B | |
| FY2025 | 31 Dec 2025 | 9.00% | 7.79B | 86.48B |
| FY2024 | 31 Dec 2024 | 9.13% | 8.05B | 88.20B |
| FY2023 | 31 Dec 2023 | 2.44% | 2.17B | 89.01B |
| FY2022 | 31 Dec 2022 | 32.83% | 31.40B | 95.66B |
| FY2021 | 31 Dec 2021 | 29.09% | 22.46B | 77.20B |
| FY2020 | 31 Dec 2020 | 11.10% | 7.02B | 63.24B |
| FY2019 | 31 Dec 2019 | 25.82% | 16.30B | 63.14B |
| FY2018 | 31 Dec 2018 | 17.64% | 11.19B | 63.41B |
| FY2017 | 31 Dec 2017 | 29.95% | 21.36B | 71.31B |
| FY2016 | 31 Dec 2016 | 12.17% | 7.25B | 59.54B |
| FY2015 | 31 Dec 2015 | 10.79% | 6.99B | 64.72B |
| FY2014 | 31 Dec 2014 | 12.86% | 9.17B | 71.30B |
| FY2013 | 31 Dec 2013 | 28.93% | 22.07B | 76.31B |
| FY2012 | 31 Dec 2012 | 17.96% | 14.60B | 81.26B |
| FY2011 | 31 Dec 2011 | 12.23% | 10.05B | 82.19B |
| FY2010 | 31 Dec 2010 | 9.44% | 8.29B | 87.81B |
| FY2009 | 31 Dec 2009 | 9.60% | 8.64B | 90.01B |
| FY2008 | 31 Dec 2008 | 14.08% | 8.10B | 57.56B |
| FY2007 | 31 Dec 2007 | 12.53% | 8.14B | 65.01B |
| FY2006 | 31 Dec 2006 | 27.10% | 19.34B | 71.36B |
| FY2005 | 31 Dec 2005 | 12.32% | 8.09B | 65.63B |
| FY2004 | 31 Dec 2004 | 16.64% | 11.36B | 68.28B |
| FY2003 | 31 Dec 2003 | 5.98% | 3.91B | 65.38B |
| FY2002 | 31 Dec 2002 | 45.74% | 9.13B | 19.95B |
| FY2001 | 31 Dec 2001 | 42.38% | 7.75B | 18.29B |
| FY2000 | 31 Dec 2000 | 23.13% | 3.72B | 16.08B |
| FY1999 | 31 Dec 1999 | 35.77% | 3.18B | 8.89B |
| FY1998 | 31 Dec 1998 | 38.04% | 3.35B | 8.81B |
| FY1997 | 31 Dec 1997 | 27.90% | 2.21B | 7.93B |
| FY1996 | 31 Dec 1996 | 27.74% | 1.93B | 6.95B |
| FY1995 | 31 Dec 1995 | 28.56% | 1.57B | 5.51B |
| FY1994 | 31 Dec 1994 | 30.03% | 1.30B | 4.32B |
| FY1993 | 31 Dec 1993 | 17.01% | 657.50M | 3.87B |
| FY1992 | 31 Dec 1992 | 23.17% | 1.09B | 4.72B |
| FY1991 | 31 Dec 1991 | 14.37% | 722.10M | 5.03B |
| FY1990 | 31 Dec 1990 | 15.73% | 801.20M | 5.09B |
| FY1989 | 31 Dec 1989 | 15.02% | 681.10M | 4.54B |
| FY1988 | 31 Dec 1988 | 18.40% | 791.30M | 4.30B |
| FY1987 | 31 Dec 1987 | 17.78% | 690.20M | 3.88B |
| FY1986 | 31 Dec 1986 | 19.32% | 660.00M | 3.42B |
| FY1985 | 31 Dec 1985 | 19.80% | 579.70M | 2.93B |
| Quarter | Period ending | ROE (return on equity) | Net income | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 27 Sept 2026 | 4.57% | 4.07B | 89.00B |
| Q2 FY2026 | 28 Jun 2026 | 5.13% | 4.37B | 85.19B |
| Q1 FY2026 | 29 Mar 2026 | 8.32% | 7.50B | 90.10B |
| Q4 FY2025 | 31 Dec 2025 | 9.00% | 7.79B | 86.48B |
| Q3 FY2025 | 28 Sept 2025 | 10.60% | 9.84B | 92.80B |
| Q2 FY2025 | 29 Jun 2025 | 12.14% | 10.77B | 88.70B |
| Q1 FY2025 | 29 Mar 2025 | — | — | 90.34B |
| Q4 FY2024 | 31 Dec 2024 | 9.13% | 8.05B | 88.20B |
| Q3 FY2024 | 29 Sept 2024 | 4.66% | 4.31B | 92.29B |
| Q2 FY2024 | 30 Jun 2024 | -2.92% | -2.56B | 87.70B |
| Q1 FY2024 | 31 Mar 2024 | -0.28% | -255.00M | 92.28B |
| Q4 FY2023 | 31 Dec 2023 | 2.44% | 2.17B | 89.01B |
| Q3 FY2023 | 1 Oct 2023 | 10.84% | 10.51B | 96.93B |
| Q2 FY2023 | 2 Jul 2023 | 21.75% | 21.54B | 99.02B |
| Q1 FY2023 | 2 Apr 2023 | 28.79% | 29.07B | 100.97B |
| Q4 FY2022 | 31 Dec 2022 | 32.82% | 31.40B | 95.66B |
| Q3 FY2022 | 2 Oct 2022 | 32.65% | 30.24B | 92.63B |
| Q2 FY2022 | 3 Jul 2022 | 34.13% | 29.77B | 87.21B |
| Q1 FY2022 | 3 Apr 2022 | 30.89% | 25.46B | 82.42B |
| Q4 FY2021 | 31 Dec 2021 | 29.09% | 22.46B | 77.20B |
| Q3 FY2021 | 3 Oct 2021 | 21.91% | 16.58B | 75.69B |
| Q2 FY2021 | 4 Jul 2021 | 15.16% | 10.62B | 70.04B |
| Q1 FY2021 | 4 Apr 2021 | 12.37% | 8.49B | 68.62B |
| Q4 FY2020 | 31 Dec 2020 | 11.10% | 7.02B | 63.24B |
| Q3 FY2020 | 27 Sept 2020 | 13.36% | 8.72B | 65.26B |
| Q2 FY2020 | 28 Jun 2020 | 22.07% | 14.20B | 64.34B |
| Q1 FY2020 | 29 Mar 2020 | 24.33% | 15.82B | 65.03B |
| Q4 FY2019 | 31 Dec 2019 | 25.82% | 16.30B | 63.14B |
| Q3 FY2019 | 29 Sept 2019 | 24.95% | 16.25B | 65.10B |
| Q2 FY2019 | 30 Jun 2019 | 21.29% | 12.68B | 59.57B |
| Q1 FY2019 | 31 Mar 2019 | 19.57% | 11.51B | 58.81B |
| Q4 FY2018 | 31 Dec 2018 | 17.64% | 11.19B | 63.41B |
| Q3 FY2018 | 30 Sept 2018 | 33.46% | 23.86B | 71.32B |
| Q2 FY2018 | 1 Jul 2018 | 32.38% | 22.60B | 69.78B |
| Q1 FY2018 | 1 Apr 2018 | 31.05% | 21.80B | 70.18B |
| Q4 FY2017 | 31 Dec 2017 | 29.95% | 21.36B | 71.31B |
| Q3 FY2017 | 1 Oct 2017 | 16.34% | 9.93B | 60.77B |
| Q2 FY2017 | 2 Jul 2017 | 14.38% | 8.39B | 58.37B |
| Q1 FY2017 | 2 Apr 2017 | 12.58% | 7.35B | 58.44B |
| Q4 FY2016 | 31 Dec 2016 | 12.17% | 7.25B | 59.54B |
| Q3 FY2016 | 2 Oct 2016 | 9.81% | 6.21B | 63.31B |
| Q2 FY2016 | 3 Jul 2016 | 11.20% | 7.03B | 62.77B |
| Q1 FY2016 | 3 Apr 2016 | 12.10% | 7.63B | 63.07B |
| Q4 FY2015 | 31 Dec 2015 | 10.79% | 6.99B | 64.72B |
| Q3 FY2015 | 27 Sept 2015 | 12.55% | 8.39B | 66.84B |
| Q2 FY2015 | 28 Jun 2015 | 13.34% | 8.93B | 66.89B |
| Q1 FY2015 | 29 Mar 2015 | 13.69% | 9.21B | 67.30B |
| Q4 FY2014 | 31 Dec 2014 | 12.86% | 9.17B | 71.30B |
| Q3 FY2014 | 28 Sept 2014 | 13.47% | 10.51B | 77.99B |
| Q2 FY2014 | 29 Jun 2014 | 13.61% | 10.43B | 76.63B |
| Q1 FY2014 | 30 Mar 2014 | 27.83% | 21.65B | 77.77B |
| Q4 FY2013 | 31 Dec 2013 | 28.93% | 22.07B | 76.31B |
| Q3 FY2013 | 29 Sept 2013 | 33.11% | 25.82B | 77.97B |
| Q2 FY2013 | 30 Jun 2013 | 33.65% | 26.43B | 78.55B |
| Q1 FY2013 | 31 Mar 2013 | 18.92% | 15.56B | 82.25B |
| Q4 FY2012 | 31 Dec 2012 | 17.96% | 14.60B | 81.26B |
| Q3 FY2012 | 30 Sept 2012 | 11.91% | 9.73B | 81.70B |
| Q2 FY2012 | 1 Jul 2012 | 12.90% | 10.26B | 79.55B |
| Q1 FY2012 | 1 Apr 2012 | 11.55% | 9.62B | 83.26B |
| Q4 FY2011 | 31 Dec 2011 | 12.23% | 10.05B | 82.19B |
| Q3 FY2011 | 2 Oct 2011 | 12.77% | 11.50B | 90.05B |
| Q2 FY2011 | 3 Jul 2011 | 9.74% | 8.62B | 88.48B |
| Q1 FY2011 | 3 Apr 2011 | 9.42% | 8.49B | 90.07B |
| Q4 FY2010 | 31 Dec 2010 | 9.44% | 8.29B | 87.81B |
| Q3 FY2010 | 3 Oct 2010 | 7.03% | 6.16B | 87.64B |
| Q2 FY2010 | 4 Jul 2010 | 9.45% | 8.17B | 86.44B |
| Q1 FY2010 | 4 Apr 2010 | 8.87% | 7.95B | 89.66B |
| Q4 FY2009 | 31 Dec 2009 | 9.60% | 8.64B | 90.01B |
| Q3 FY2009 | 27 Sept 2009 | 12.31% | 8.14B | 66.16B |
| Q2 FY2009 | 28 Jun 2009 | 11.96% | 7.54B | 63.04B |
| Q1 FY2009 | 29 Mar 2009 | 13.36% | 8.05B | 60.26B |
| Q4 FY2008 | 31 Dec 2008 | 14.08% | 8.10B | 57.56B |
| Q3 FY2008 | 28 Sept 2008 | 15.69% | 10.56B | 67.34B |
| Q2 FY2008 | 29 Jun 2008 | 13.59% | 9.05B | 66.57B |
| Q1 FY2008 | 30 Mar 2008 | 11.18% | 7.54B | 67.42B |
| Q4 FY2007 | 31 Dec 2007 | 12.53% | 8.14B | 65.01B |
| Q3 FY2007 | 30 Sept 2007 | 22.32% | 14.87B | 66.61B |
| Q2 FY2007 | 1 Jul 2007 | 25.66% | 17.47B | 68.09B |
| Q1 FY2007 | 1 Apr 2007 | 25.68% | 18.62B | 72.49B |
| Q4 FY2006 | 31 Dec 2006 | 27.10% | 19.34B | 71.36B |
| Q3 FY2006 | 1 Oct 2006 | 18.10% | 12.62B | 69.71B |
| Q2 FY2006 | 2 Jul 2006 | 15.84% | 10.85B | 68.49B |
| Q1 FY2006 | 2 Apr 2006 | 17.09% | 11.90B | 69.61B |
| Q4 FY2005 | 31 Dec 2005 | 12.32% | 8.09B | 65.63B |
| Q3 FY2005 | 2 Oct 2005 | 12.24% | 8.18B | 66.81B |
| Q2 FY2005 | 3 Jul 2005 | 15.20% | 9.93B | 65.33B |
| Q1 FY2005 | 3 Apr 2005 | 13.82% | 9.33B | 67.53B |
| Q4 FY2004 | 31 Dec 2004 | 16.64% | 11.36B | 68.28B |
| Q3 FY2004 | 26 Sept 2004 | 13.36% | 9.14B | 68.38B |
| Q2 FY2004 | 27 Jun 2004 | 12.04% | 8.03B | 66.71B |
| Q1 FY2004 | 28 Mar 2004 | 2.28% | 1.58B | 69.05B |
| Q4 FY2003 | 31 Dec 2003 | 5.98% | 3.91B | 65.38B |
| Q3 FY2003 | 28 Sept 2003 | 8.99% | 6.16B | 68.53B |
| Q2 FY2003 | 29 Jun 2003 | 8.93% | 6.28B | 70.28B |
| Q1 FY2003 | 30 Mar 2003 | 46.03% | 11.44B | 24.84B |
| Q4 FY2002 | 31 Dec 2002 | 45.74% | 9.13B | 19.95B |
| Q3 FY2002 | 29 Sept 2002 | 43.41% | 8.23B | 18.95B |
| Q2 FY2002 | 30 Jun 2002 | 42.22% | 7.95B | 18.83B |
| Q1 FY2002 | 31 Mar 2002 | 41.57% | 8.18B | 19.67B |
| Q4 FY2001 | 31 Dec 2001 | 42.38% | 7.75B | 18.29B |
| Q3 FY2001 | 30 Sept 2001 | 38.14% | 7.21B | 18.90B |
| Q2 FY2001 | 1 Jul 2001 | 36.46% | 6.50B | 17.82B |
| Q1 FY2001 | 1 Apr 2001 | 25.17% | 4.47B | 17.75B |
| Q4 FY2000 | 31 Dec 2000 | 23.13% | 3.72B | 16.08B |
| Q3 FY2000 | 1 Oct 2000 | 20.16% | 3.26B | 16.17B |
| Q2 FY2000 | 2 Jul 2000 | 17.36% | 2.60B | 14.97B |
| Q1 FY2000 | 2 Apr 2000 | 34.79% | 3.54B | 10.19B |
| Q4 FY1999 | 31 Dec 1999 | 35.77% | 3.18B | 8.89B |
| Q3 FY1999 | 3 Oct 1999 | 32.54% | 2.86B | 8.79B |
| Q2 FY1999 | 4 Jul 1999 | 41.09% | 3.56B | 8.65B |
| Q1 FY1999 | 4 Apr 1999 | 38.41% | 3.47B | 9.05B |
| Q4 FY1998 | 31 Dec 1998 | 38.04% | 3.35B | 8.81B |
| Q3 FY1998 | 27 Sept 1998 | 37.88% | 3.28B | 8.65B |
| Q2 FY1998 | 28 Jun 1998 | 29.79% | 2.47B | 8.31B |
| Q1 FY1998 | 29 Mar 1998 | 28.12% | 2.30B | 8.19B |
| Q4 FY1997 | 31 Dec 1997 | 27.90% | 2.21B | 7.93B |
| Q3 FY1997 | 28 Sept 1997 | 29.16% | 2.16B | 7.41B |
| Q2 FY1997 | 29 Jun 1997 | 28.95% | 2.08B | 7.17B |
| Q1 FY1997 | 30 Mar 1997 | 28.16% | 2.01B | 7.15B |
| Q4 FY1996 | 31 Dec 1996 | 27.74% | 1.93B | 6.95B |
| Q3 FY1996 | 29 Sept 1996 | 27.96% | 1.84B | 6.57B |
| Q2 FY1996 | 30 Jun 1996 | 29.20% | 1.75B | 5.98B |
| Q1 FY1996 | 31 Mar 1996 | 28.35% | 1.67B | 5.89B |
| Q4 FY1995 | 31 Dec 1995 | 28.56% | 1.57B | 5.51B |
| Q3 FY1995 | 1 Oct 1995 | 28.33% | 1.50B | 5.28B |
| Q2 FY1995 | 2 Jul 1995 | 29.14% | 1.41B | 4.83B |
| Q1 FY1995 | 2 Apr 1995 | 28.70% | 1.35B | 4.70B |
| Q4 FY1994 | 31 Dec 1994 | 30.03% | 1.30B | 4.32B |
| Q3 FY1994 | 2 Oct 1994 | 30.17% | 1.25B | 4.15B |
| Q2 FY1994 | 3 Jul 1994 | 18.75% | 702.60M | 3.75B |
| Q1 FY1994 | 3 Apr 1994 | 18.21% | 699.20M | 3.84B |
| Q4 FY1993 | 31 Dec 1993 | 17.01% | 657.50M | 3.87B |
| Q3 FY1993 | 30 Sept 1993 | 17.42% | 665.70M | 3.82B |
| Q2 FY1993 | 30 Jun 1993 | 27.98% | 1.18B | 4.21B |
| Q1 FY1993 | 31 Mar 1993 | 25.32% | 1.13B | 4.45B |
| Q4 FY1992 | 31 Dec 1992 | 23.17% | 1.09B | 4.72B |
| Q3 FY1992 | 30 Sept 1992 | 14.57% | 797.30M | 5.47B |
| Q2 FY1992 | 30 Jun 1992 | 15.38% | 774.50M | 5.03B |
| Q1 FY1992 | 31 Mar 1992 | 14.81% | 749.80M | 5.06B |
| Q4 FY1991 | 31 Dec 1991 | 14.37% | 722.10M | 5.03B |
| Q3 FY1991 | 30 Sept 1991 | 17.28% | 876.00M | 5.07B |
| Q2 FY1991 | 30 Jun 1991 | 17.49% | 844.60M | 4.83B |
| Q1 FY1991 | 31 Mar 1991 | 15.77% | 816.70M | 5.18B |
| Q4 FY1990 | 31 Dec 1990 | 15.73% | 801.20M | 5.09B |
| Q3 FY1990 | 30 Sept 1990 | — | — | 5.01B |
| Q2 FY1990 | 30 Jun 1990 | — | — | 4.68B |
| Q1 FY1990 | 31 Mar 1990 | — | — | 4.74B |
| Q4 FY1989 | 31 Dec 1989 | — | — | 4.54B |
| Q3 FY1989 | 30 Sept 1989 | — | — | — |
| Q2 FY1989 | 30 Jun 1989 | — | — | — |
| Q1 FY1989 | 31 Mar 1989 | — | — | — |
| Q4 FY1988 | 31 Dec 1988 | — | — | 4.30B |
| Q3 FY1988 | 30 Sept 1988 | — | — | — |
| Q2 FY1988 | 30 Jun 1988 | — | — | — |
| Q1 FY1988 | 31 Mar 1988 | — | — | — |
| Q4 FY1987 | 31 Dec 1987 | — | — | 3.88B |
| Q3 FY1987 | 30 Sept 1987 | — | — | — |
| Q2 FY1987 | 30 Jun 1987 | — | — | — |
| Q1 FY1987 | 31 Mar 1987 | — | — | — |
| Q4 FY1986 | 31 Dec 1986 | — | — | 3.42B |
| Q3 FY1986 | 30 Sept 1986 | — | — | — |
| Q2 FY1986 | 30 Jun 1986 | — | — | — |
| Q1 FY1986 | 31 Mar 1986 | — | — | — |
| Q4 FY1985 | 31 Dec 1985 | — | — | 2.93B |
| Q3 FY1985 | 30 Sept 1985 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios
Common questions about Pfizer's ROE
Source: Financial Modeling Prep